Get the Stockscreener App
4.85
6.13%
0.28
Scpharmaceuticals Inc stock is traded at $4.85, with a volume of 289.25K.
It is up +6.13% in the last 24 hours and down -9.85% over the past month.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.
See More
Previous Close:
$4.57
Open:
$4.6
24h Volume:
289.25K
Relative Volume:
0.86
Market Cap:
$258.50M
Revenue:
$17.63M
Net Income/Loss:
$-57.71M
P/E Ratio:
-3.277
EPS:
-1.48
Net Cash Flow:
$-60.45M
1W Performance:
+5.43%
1M Performance:
-9.85%
6M Performance:
+49.23%
1Y Performance:
-5.64%
1-Day Range:
$4.575
$4.90
1-Week Range:
$4.33
$4.90
52-Week Range:
$1.94
$6.2799
Scpharmaceuticals Inc Stock (SCPH) Company Profile
Name
Scpharmaceuticals Inc
Sector
Industry
Phone
617-517-0730
Address
25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA
Compare SCPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCPH
Scpharmaceuticals Inc
|
4.85 | 254.77M | 17.63M | -57.71M | -60.45M | -1.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-07-23 | Initiated | Craig Hallum | Buy |
| Dec-01-22 | Initiated | Cowen | Outperform |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Oct-11-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Aug-02-22 | Initiated | Maxim Group | Buy |
| Sep-09-21 | Initiated | SVB Leerink | Mkt Perform |
| Oct-15-19 | Initiated | H.C. Wainwright | Buy |
| Jan-30-19 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
View All
Scpharmaceuticals Inc Stock (SCPH) Latest News
Technical analysis overview for scPharmaceuticals Inc. stock2025 Earnings Surprises & Fast Momentum Entry Tips - Newser
Published on: 2025-08-20 16:32:29 - beatles.ru
What’s next for scPharmaceuticals Inc. stock priceEarnings Trend Report & Precise Swing Trade Entry Alerts - Newser
Quantitative breakdown of scPharmaceuticals Inc. recent move2025 Dividend Review & Weekly Top Gainers Alerts - Newser
Why scPharmaceuticals Inc. is moving todayMarket Sentiment Summary & Reliable Entry Point Alerts - Newser
Building trade automation scripts for scPharmaceuticals Inc.July 2025 Closing Moves & Consistent Income Trade Ideas - Newser
Published on: 2025-08-20 01:04:39 - Newser
Using R and stats models for scPharmaceuticals Inc. forecastingJuly 2025 Patterns & Risk Controlled Daily Plans - Newser
scPharmaceuticals secures notice of allowances of multiple US patent applications covering SCP-111 - MSN
scPharmaceuticals Inc. Stock Performance After Earnings: Historical Insights2025 Momentum Check & Consistent Profit Trading Strategies - Newser
Risk adjusted return profile for scPharmaceuticals Inc. analyzedJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - Newser
What data driven models say about scPharmaceuticals Inc.’s futureJuly 2025 Spike Watch & Daily Oversold Bounce Ideas - Newser
Real time pattern detection on scPharmaceuticals Inc. stockWeekly Stock Report & Daily Oversold Bounce Ideas - Newser
Published on: 2025-08-19 05:55:07 - Newser
Can scPharmaceuticals Inc. Escape Recent Bear Channel2025 Price Targets & Daily Stock Trend Watchlist - classian.co.kr
What earnings revisions data tells us about scPharmaceuticals Inc.Insider Selling & High Win Rate Trade Tips - Newser
Analyzing scPharmaceuticals Inc. with multi timeframe chartsMarket Trend Review & Low Risk Profit Maximizing Plans - Newser
Does scPharmaceuticals Inc. qualify in momentum factor screeningEarnings Performance Report & Weekly Setup with High ROI Potential - Newser
scPharmaceuticals Inc. stock trendline breakdownJuly 2025 Catalysts & Capital Efficiency Focused Strategies - Newser
What institutional flow reveals about scPharmaceuticals Inc.Market Risk Report & Community Trade Idea Sharing Platform - Newser
What Fibonacci levels say about scPharmaceuticals Inc. reboundJuly 2025 Trade Ideas & Daily Technical Forecast Reports - Newser
Published on: 2025-08-17 04:06:24 - Newser
RSI Crosses Above 30 for scPharmaceuticals Inc. — Reversal in SightBreakout Watch & Scalable Portfolio Growth Ideas - 선데이타임즈
What makes scPharmaceuticals Inc. stock price move sharply2025 Trading Recap & Scalable Portfolio Growth Methods - Newser
Using data tools to time your scPharmaceuticals Inc. exitJuly 2025 Highlights & Real-Time Buy Signal Notifications - Newser
Is scPharmaceuticals Inc. forming a reversal pattern2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
Is scPharmaceuticals Inc. a candidate for recovery playJuly 2025 Summary & Comprehensive Market Scan Reports - Newser
Is scPharmaceuticals Inc. stock bottoming outJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
Momentum divergence signals in scPharmaceuticals Inc. chartMarket Volume Summary & Weekly Momentum Stock Picks - Newser
Why scPharmaceuticals Inc. stock attracts strong analyst attentionJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Can a trend reversal in scPharmaceuticals Inc. lead to recoveryEarnings Summary Report & AI Enhanced Trading Alerts - Newser
Sentiment analysis tools applied to scPharmaceuticals Inc.2025 Biggest Moves & Safe Swing Trade Setups - Newser
Published on: 2025-08-15 05:16:39 - sundaytimes.kr
Scpharmaceuticals Inc Stock (SCPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):